|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 121, Issue 12 4265-4273, Copyright © 1995 by Company of Biologists
JOURNAL ARTICLES |
SS Scherer, YT Xu, PG Bannerman, DL Sherman and PJ Brophy
Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia 19104-6146, USA.
Periaxin is a newly described protein that is expressed exclusively by myelinating Schwann cells. In developing nerves, periaxin is first detected as Schwann cells ensheathe axons, prior to the appearance of the proteins that characterize the myelin sheath. Periaxin is initially concentrated in the adaxonal membrane (apposing the axon) but, during development, as myelin sheaths mature, periaxin becomes predominately localized at the abaxonal Schwann cell membrane (apposing the basal lamina). In permanently axotomized adult nerves, periaxin is lost from the abaxonal and adaxonal membranes, becomes associated with degenerating myelin sheaths and is phagocytosed by macrophages. In crushed nerves, in which axons regenerate and are remyelinated, periaxin is first detected in the adoxonal membrane as Schwann cells ensheathe regenerating axons, but again prior to the appearance of other myelin proteins. Periaxin mRNA and protein levels change in parallel with those of other myelin-related genes after permanent axotomy and crush. These data demonstrate that periaxin is expressed by myelinating Schwann cells in a dynamic, developmentally regulated manner. The shift in localization of periaxin in the Schwann cell after completion of the spiralization phase of myelination suggests that periaxin participates in membrane-protein interactions that are required to stabilize the mature myelin sheath.
This article has been cited by other articles:
|
|
 |
|
  N. Komori, N. Takemori, H. K. Kim, A. Singh, S.-H. Hwang, R. D. Foreman, K. Chung, J. M. Chung, and H. Matsumoto Proteomics study of neuropathic and nonneuropathic dorsal root ganglia: altered protein regulation following segmental spinal nerve ligation injury Physiol Genomics, April 24, 2007; 29(2): 215 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Parkinson, A. Bhaskaran, A. Droggiti, S. Dickinson, M. D'Antonio, R. Mirsky, and K. R. Jessen Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death J. Cell Biol., February 2, 2004; 164(3): 385 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Guilbot, A. Williams, N. Ravise, C. Verny, A. Brice, D. L. Sherman, P. J. Brophy, E. LeGuern, V. Delague, C. Bareil, et al. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease Hum. Mol. Genet., February 1, 2001; 10(4): 415 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Sherman and P. J. Brophy A Tripartite Nuclear Localization Signal in the PDZ-domain Protein L-periaxin J. Biol. Chem., February 18, 2000; 275(7): 4537 - 4540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Dytrych, D. L. Sherman, C. S. Gillespie, and P. J. Brophy Two PDZ Domain Proteins Encoded by the Murine Periaxin Gene Are the Result of Alternative Intron Retention and Are Differentially Targeted in Schwann Cells J. Biol. Chem., March 6, 1998; 273(10): 5794 - 5800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gillen, C. Korfhage, and H. W. Muller {blacksquare} REVIEW : Gene Expression in Nerve Regeneration Neuroscientist, March 1, 1997; 3(2): 112 - 122. [Abstract] [PDF]
|
|
|
|
 |
|
 J. B. Grinspan, M. A. Marchionni, M. Reeves, M. Coulaloglou, and S. S. Scherer Axonal Interactions Regulate Schwann Cell Apoptosis in Developing Peripheral Nerve: Neuregulin Receptors and the Role of Neuregulins J. Neurosci., October 1, 1996; 16(19): 6107 - 6118. [Abstract] [Full Text] [PDF]
|
|
